These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34844839)

  • 21. Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
    Saad F; Hotte SJ; Finelli A; Malone S; Niazi T; Noonan K; Shayegan B; So AI; Danielson B; Basappa NS; Cagiannos I; Canil C; Delouya G; Fernandes R; Ferrario C; Gotto GT; Hamilton RJ; Izard JP; Kapoor A; Khalaf D; Kolinsky M; Lalani AK; Lavallée LT; Morash C; Morgan SC; Ong M; Pouliot F; Rendon RA; Yip S; Zardan A; Park-Wyllie L; Chi K
    Can Urol Assoc J; 2021 Oct; 15(10):353-358. PubMed ID: 34125066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.
    Elghazaly H; Mottet N; Garcia J; Oudard S; Roach M; Abbou C; Merseburger A; Emara A; Shehata S; Tawfik H; Khorshid O; Selim A; Assem A; Abdelkarim K; Ezz El-Arab L; Bazarbashi S; Omar A; Elwakil H; Elashry M; Abou ElFotouh M; Osman T; Ezz El Din M
    World J Urol; 2021 May; 39(5):1421-1429. PubMed ID: 32643031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.
    Maluf F; Soares A; Avanço G; Hada AL; Cardoso APG; Carneiro A; Herchenhorn D; Jardim DLF; Schutz FA; Kater FR; Pereira FMT; Monteiro FSM; Morbeck IAP; Reolon JFN; da Trindade KM; Andrade LMQDS; Nogueira LM; Furoni R; Natel RA; Dos Reis RB; Fogace RN; Souza VC
    Int Braz J Urol; 2021; 47(2):359-373. PubMed ID: 33284538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
    Khauli R; Ferrigno R; Guimarães G; Bulbulan M; Uson Junior PLS; Salvajoli B; Palhares DMF; Racy D; Gil E; de Arruda FF; Lemos GC; Carvalhal GF; de Carvalho IT; Martins IAF; Gimpel IFP; Salvajoli JV; Chambo JL; Pontes J; Filho LAR; Nogueira L; Freitas MRP; Wroclawski M; Arap MA; Sadi MV; Coelho R; Gadia R; Roja RAL; Hanriot RM; Baroni R; Zequi S; Nahas WC; Alfer W; Maluf FC
    JCO Glob Oncol; 2021 Apr; 7():530-537. PubMed ID: 33856890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
    Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
    Sumanasuriya S; Omlin A; Armstrong A; Attard G; Chi KN; Bevan CL; Shibakawa A; IJzerman MJ; De Laere B; Lolkema M; Lorente D; Luo J; Mehra N; Olmos D; Scher H; Soule H; Stoecklein NH; Terstappen LWMM; Waugh D; de Bono JS
    Eur Urol Oncol; 2018 Jun; 1(2):151-159. PubMed ID: 31100240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.
    Mehra N; Kloots I; Vlaming M; Aluwini S; Dewulf E; Oprea-Lager DE; van der Poel H; Stoevelaar H; Yakar D; Bangma CH; Bekers E; van den Bergh R; Bergman AM; van den Berkmortel F; Boudewijns S; Dinjens WNM; Fütterer J; van der Hulle T; Jenster G; Kroeze LI; van Kruchten M; van Leenders G; van Leeuwen PJ; de Leng WWJ; van Moorselaar RJA; Noordzij W; Oldenburg RA; van Oort IM; Oving I; Schalken JA; Schoots IG; Schuuring E; Smeenk RJ; Vanneste BGL; Vegt E; Vis AN; de Vries K; Willemse PM; Wondergem M; Ausems M
    Eur Urol Open Sci; 2023 Mar; 49():23-31. PubMed ID: 36874601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
    Oprea-Lager DE; MacLennan S; Bjartell A; Briganti A; Burger IA; de Jong I; De Santis M; Eberlein U; Emmett L; Fizazi K; Gillessen S; Herrmann K; Heskamp S; Iagaru A; Jereczek-Fossa BA; Kunikowska J; Lam M; Nanni C; O'Sullivan JM; Panebianco V; Sala E; Sathekge M; Sosnowski R; Tilki D; Tombal B; Treglia G; Tunariu N; Walz J; Yakar D; Dierckx R; Sartor O; Fanti S
    Eur Urol; 2024 Jan; 85(1):49-60. PubMed ID: 37743194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
    Saad F; Hotte SJ; Noonan K; Malone S; Morash C; Niazi T; Rendon RA; Shayegan B; Basappa NS; Cagiannos I; Danielson B; Delouya G; Fernandes R; Ferrario C; Finelli A; Gotto GT; Hamilton RJ; Izard JP; Kapoor A; Lalani AK; Lavallée LT; Ong M; Pouliot F; So AI; Yip S; Chi KN
    Can Urol Assoc J; 2024 Apr; 18(4):E127-E137. PubMed ID: 38381937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
    Saad F; Canil C; Finelli A; Hotte SJ; Malone S; Shayegan B; So AI; Aaron L; Basappa NS; Conter HJ; Danielson B; Gotto G; Hamilton RJ; Izard JP; Kapoor A; Kolinsky M; Lalani AA; Lattouf JB; Morash C; Morgan SC; Niazi T; Noonan KL; Ong M; Rendon RA; Sehdev S; Hew H; Park-Wyllie L; Chi KN
    Can Urol Assoc J; 2020 Apr; 14(4):E137-E149. PubMed ID: 31702544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries.
    Monteiro FSM; Schutz FA; Morbeck IAP; Bastos DA; de Padua FV; Costa LAGA; Maia MC; Rinck JA; Zequi SC; da Trindade KM; Alfer W; Nahas WC; Dos Santos LV; Ferrigno R; da Rosa DAR; Sade JP; Orlandi FJ; de Oliveira FNG; Soares A
    JCO Glob Oncol; 2021 Apr; 7():538-544. PubMed ID: 33856897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
    Aluwini SS; Mehra N; Lolkema MP; Oprea-Lager DE; Yakar D; Stoevelaar H; van der Poel H; ; Busstra M; de Jong IJ; de Reijke T; de Vries K; Heijmink S; Jenster G; Klaver S; Kneppers J; Lavalaye J; Leyten G; Moonen L; Nagaraj J; Noordzij W; Osanto S; Oving I; Schaake E; Scheenen T; Schoots I; Sedelaar M; Somford D; van den Berkmortel F; van der Hulle T; van der Voort van Zyp J; van Leeuwen P; van Moorselaar J; van Oort I; Vogel W; Westgeest H
    Eur Urol Oncol; 2020 Apr; 3(2):231-238. PubMed ID: 31401014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [
    Fanti S; Briganti A; Emmett L; Fizazi K; Gillessen S; Goffin K; Hadaschik BA; Herrmann K; Kunikowska J; Maurer T; MacLennan S; Mottet N; Murphy DG; Oprea-Lager DE; O'Sullivan JM; Oyen WJG; Rouvière O; Sartor O; Stenzl A; Van Poppel H; Walz J; Witjes W; Bjartell A
    Eur Urol Oncol; 2022 Oct; 5(5):530-536. PubMed ID: 35697600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al.
    Gillessen S; Fanti S; Omlin A;
    Ann Oncol; 2015 Nov; 26(11):2354-5. PubMed ID: 26347101
    [No Abstract]   [Full Text] [Related]  

  • 35. Controversies in prostate cancer management: Consensus recommendations from experts in northern Spain.
    Pérez Fentes D; Willisch P; Martínez Breijoo S; Domínguez M; Anido U; Álvarez C; Gómez Caamaño A
    Actas Urol Esp (Engl Ed); 2024 Jul; ():. PubMed ID: 38960063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
    von Eyben FE; Virgolini I; Roviello G
    Eur Urol; 2018 Feb; 73(2):e31. PubMed ID: 28869068
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.
    Fitzpatrick JM; Bellmunt J; Fizazi K; Heidenreich A; Sternberg CN; Tombal B; Alcaraz A; Bahl A; Bracarda S; Di Lorenzo G; Efstathiou E; Finn SP; Fosså S; Gillessen S; Kellokumpu-Lehtinen PL; Lecouvet FE; Oudard S; de Reijke TM; Robson CN; De Santis M; Seruga B; de Wit R
    Eur J Cancer; 2014 Jun; 50(9):1617-27. PubMed ID: 24703899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
    Gómez-Caamaño A; González-San Segundo C; Henríquez I; Maldonado X; Zapatero A;
    Clin Transl Oncol; 2019 Apr; 21(4):420-432. PubMed ID: 30293231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
    Luz MA; Guimarães GC; Nardi AC; Pompeo ASFL; Sarkis ÁS; Nowier A; Lima Pompeo AC; Nardozza A; Adamy A; Carneiro A; Salvajoli BP; Benigno BS; Freitas CH; Chade CADC; Palhares DMF; Otero DAC; Neto DCVDS; Carvalhal EF; Gil E; Freire de Arruda F; Korkes F; Caserta Lemos G; Carvalhal GF; de Carvalho ÍT; Gimpel IFP; Chambô JL; Pontes J; Filho LAR; Nogueira LM; Wroclawski ML; Freitas MRP; Arap MA; Sadi MV; Bulbul M; Coelho RF; Gadia R; Khauli RB; Dos Reis RB; Rojas RAL; Guimarães RG; Aldousari S; Ferrigno R
    JCO Glob Oncol; 2021 Apr; 7():523-529. PubMed ID: 33856894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
    Gillessen S; de Bono JS; Sartor O; Omlin AG
    Eur Urol; 2018 Feb; 73(2):e32-e33. PubMed ID: 28869069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.